Zinc acetate lozenges may shorten common cold duration by up to 40%

Show full item record

Permalink

http://hdl.handle.net/10138/40083

Citation

Hemilä , H 2012 , ' Zinc acetate lozenges may shorten common cold duration by up to 40% : [Comment] ' CMAJ , vol 184 , no. 10 , pp. E551-E561 . , 10.1503/cmaj.111990

Title: Zinc acetate lozenges may shorten common cold duration by up to 40%;
[Comment]
Author: Hemilä, Harri
Contributor: University of Helsinki, Hjelt Institute
Belongs to series: CMAJ
ISSN: 0820-3946
Abstract: The systematic review by Dr. Science et al. has a number of problems. ... Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).
Peer review status: Non peer reviewed
URI: http://hdl.handle.net/10138/40083
Date: 2012
Subject: 3125 Otorhinolaryngology, ophthalmology
317 Pharmacy
upper respiratory infections
zinc lozenges
RANDOMIZED TRIALS
Systematic review


Files in this item

Total number of downloads: Loading...

Files Size Format View
CMAJ2012_ZincProblems.pdf 83.09Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record